المؤلفون: De Mattos Arruda, Leticia

المساهمون: University/Department: Universitat Autònoma de Barcelona. Departament de Medicina

مرشدي الرسالة: Seoane, Joan, Cortes, Javier, Bosch Gil, Josep Angel

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Liquid biopsy, cfDNA, Cerebrospinal fluid, Ciències Humanes

وصف الملف: application/pdf

الوصول الحر: http://hdl.handle.net/10803/394019Test

المؤلفون: Barajas, Ana, Amengual-Rigo, Pep, Pons-Grífols, Anna, Ortiz, Raquel, Gracia Carmona, Oriol, Urrea, Victor, de la Iglesia, Nuria, Blanco-Heredia, Juan, Anjos-Souza, Carla, Varela, Ismael, Trinité, Benjamin, Tarrés-Freixas, Ferran, Rovirosa, Carla, Lepore, Rosalba, Vázquez, Miguel, de Mattos-Arruda, Leticia, Valencia, Alfonso, Clotet, Bonaventura, Aguilar-Gurrieri, Carmen, Guallar, Victor, Carrillo, Jorge, Blanco, Julià

المساهمون: Departament de Salut, Generalitat de Catalunya, Ministerio de Ciencia e Innovación, Secretaria d'Universitats i Recerca - Generalitat de Catalunya, Grifols, Sorigué

المصدر: Journal of Translational Medicine ; volume 22, issue 1 ; ISSN 1479-5876

مصطلحات موضوعية: General Biochemistry, Genetics and Molecular Biology, General Medicine

الإتاحة: https://doi.org/10.1186/s12967-023-04843-8Test

المؤلفون: Magbanua, Mark Jesus M, Hendrix, Laura H, Hyslop, Terry, Barry, William T, Winer, Eric P, Hudis, Clifford, Toppmeyer, Deborah, Carey, Lisa Anne, Partridge, Ann H, Pierga, Jean-Yves, Fehm, Tanja, Vidal-Martínez, José, Mavroudis, Dimitrios, Garcia-Saenz, Jose A, Stebbing, Justin, Gazzaniga, Paola, Manso, Luis, Zamarchi, Rita, Antelo, María Luisa, De Mattos-Arruda, Leticia, Generali, Daniele, Caldas, Carlos, Munzone, Elisabetta, Dirix, Luc, Delson, Amy L, Burstein, Harold J, Qadir, Misbah, Ma, Cynthia, Scott, Janet H, Bidard, François-Clément, Park, John W, Rugo, Hope S

المصدر: Journal of the National Cancer Institute. 113(4)

مصطلحات موضوعية: Cancer, Prevention, Breast Cancer, Clinical Research, Breast Neoplasms, Female, Humans, Neoplastic Cells, Circulating, Prognosis, Progression-Free Survival, Proportional Hazards Models, Reproducibility of Results, Retrospective Studies, Treatment Outcome, Oncology and Carcinogenesis, Oncology & Carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/376347vbTest

المؤلفون: Gerratana, Lorenzo, Pierga, Jean-Yves, Reuben, James M, Davis, Andrew A, Wehbe, Firas H, Dirix, Luc, Fehm, Tanja, Nolé, Franco, Gisbert-Criado, Rafael, Mavroudis, Dimitrios, Grisanti, Salvatore, Garcia-Saenz, Jose A, Stebbing, Justin, Caldas, Carlos, Gazzaniga, Paola, Manso, Luis, Zamarchi, Rita, Bonotto, Marta, Fernandez de Lascoiti, Angela, De Mattos-Arruda, Leticia, Ignatiadis, Michail, Sandri, Maria-Teresa, Generali, Daniele, De Angelis, Carmine, Dawson, Sarah-Jane, Janni, Wolfgang, Carañana, Vicente, Riethdorf, Sabine, Solomayer, Erich-Franz, Puglisi, Fabio, Giuliano, Mario, Pantel, Klaus, Bidard, François-Clément, Cristofanilli, Massimo

المساهمون: Gerratana, Lorenzo, Pierga, Jean-Yve, Reuben, James M, Davis, Andrew A, Wehbe, Firas H, Dirix, Luc, Fehm, Tanja, Nolé, Franco, Gisbert-Criado, Rafael, Mavroudis, Dimitrio, Grisanti, Salvatore, Garcia-Saenz, Jose A, Stebbing, Justin, Caldas, Carlo, Gazzaniga, Paola, Manso, Lui, Zamarchi, Rita, Bonotto, Marta, Fernandez de Lascoiti, Angela, De Mattos-Arruda, Leticia, Ignatiadis, Michail, Sandri, Maria-Teresa, Generali, Daniele, De Angelis, Carmine, Dawson, Sarah-Jane, Janni, Wolfgang, Carañana, Vicente, Riethdorf, Sabine, Solomayer, Erich-Franz, Puglisi, Fabio, Giuliano, Mario, Pantel, Klau, Bidard, François-Clément, Cristofanilli, Massimo

مصطلحات موضوعية: K-nearest neighbor, biomarker, clinical trial model, liquid biopsy, machine learning

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35278078; info:eu-repo/semantics/altIdentifier/wos/WOS:000768371800001; volume:27; issue:7; firstpage:e561; lastpage:e570; numberofpages:10; journal:THE ONCOLOGIST; http://hdl.handle.net/11368/3017431Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85130980801; https://academic.oup.com/oncolo/article/27/7/e561/6547707Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255982Test/

الإتاحة: https://doi.org/10.1093/oncolo/oyac045Test
http://hdl.handle.net/11368/3017431Test
https://academic.oup.com/oncolo/article/27/7/e561/6547707Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255982Test/

المؤلفون: Sammut, Stephen-John, Galson, Jacob D., Minter, Ralph, Sun, Bo, Chin, Suet-Feung, De Mattos-Arruda, Leticia, Finch, Donna K., Schätzle, Sebastian, Dias, Jorge, Rueda, Oscar M., Seoane, Joan, Osbourn, Jane, Caldas, Carlos, Bashford-Rogers, Rachael J. M.

المصدر: Nature Immunology; May 2024, Vol. 25 Issue: 5 p916-924, 9p

المؤلفون: Pascual, Javier, Attard, Gerhardt, Bidard, François Clément, Curigliano, Giuseppe, de Mattos-Arruda, Leticia, Diehn, Maximilian, Italiano, Antoine, Lindberg, Johan F., Merker, Jason D., Montagut, Clara, Normanno, Nicola, Pantel, Klaus, Pentheroudakis, George, Popat, Sanjay, Reis-Filho, Jorge Sérgio, Tie, Jeanne, Seoane, Joan, Tarazona, Noelia, Yoshino, Takayuki, Turner, Nicholas C.

المساهمون: Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institut Curie Paris, Département d’Innovation Thérapeutique et essais précoces Gustave Roussy (DITEP), Institut Gustave Roussy (IGR), Université de Bordeaux (UB), Institut Bergonié Bordeaux, UNICANCER, National Institutes of Health, NIH, American Association for Cancer Research, AACR, National Cancer Institute, NCI: 1-UG1-CA233333-01, Boehringer Ingelheim, BI, Mesothelioma Applied Research Foundation, MARF, Amgen, Bristol-Myers Squibb, BMS, Eli Lilly and Company, Pfizer, Philips, Astellas Pharma US, APUS, AstraZeneca, Bayer, Genentech, GlaxoSmithKline, GSK, Merck, Novartis, Roche, Sanofi, European Association for Cancer Research, EACR, Stanford University, SU, International Association for the Study of Lung Cancer, IASLC, Ariad Pharmaceuticals, Celgene, F. Hoffmann-La Roche, Boehringer Ingelheim, Takeda Pharmaceutical Company, TPC, Janssen Pharmaceuticals, Merck KGaA, Merck Sharp and Dohme, MSD, Chugai Pharmaceutical, Association for Molecular Pathology, AMP, ANGLE, Fondazione Beretta, Roche Innovation Center Zurich, RICZ, Daiichi-Sankyo, European Society for Medical Oncology, ESMO, Ipsen, GA reports receipt of honoraria for participation in Advisory Board from Astellas, AstraZeneca, Bayer, Janssen, Novartis, Orion, Pfizer, Sanofi, Sapience, receipt of honoraria as invited speaker from Astellas, AstraZeneca, Janssen, receipt of royalties for licensing fees from Janssen, receipt of institutional research grants from Astellas and Janssen, non-remunerated activities as a PI in Astellas, Janssen, and non-remunerated advisory role in AstraZeneca and Janssen, FCB reports receipt of honoraria for participation in Advisory Board from Archer, BioNTech, Lilly, Novartis, Pfizer, receipt of honoraria to institution for participation in Advisory Board from AstraZeneca, receipt of honoraria as invited speaker from AstraZeneca, Novartis, Pfizer, Roche, Seagen, receipt of honoraria to institution as invited speaker from Pfizer, Sanofi, receipt of honoraria for expert testimony from Hikma, institutional non-financial interest for research as a coordinating PI from AstraZeneca, Pfizer, ProLynx, Saga and Seagen, GC reports receipt of honoraria for participation in Advisory Board from AstraZeneca, Bristol Myers Squibb (BMS), Daiichi Sankyo, Ellipsis, Exact Sciences, Lilly, Merck, Pfizer, Roche, Veracyte, receipt of honoraria as invited speaker from AstraZeneca, Daiichi Sankyo, Novartis, Pfizer, Roche, receipt of honoraria for writing engagement from Pfizer, institutional research grant for investigator initiated clinical trial from Merck, institutional funding for conduct of phase I studies from Astellas, AstraZeneca, Blueprint Medicine, BMS, Daiichi Sankyo, Kymab, Novartis, Philogen, Roche, Sanofi, non-remunerated activities as an officer of the Italian National Health Council—Advisor for Ministry of Health, non-remunerated advisory role as a member of the Scientific Council of Europa Donna, non-remunerated advisory role in Fondazione Beretta, and non-remunerated member of Board of Directors of the Lega Italiana Lotta ai Tumori, LDMA reports receipt of honoraria as invited speaker, participation in speaker bureau from Roche, institutional research collaboration grant from NanoString and receipt of education grant from BMS, MD reports receipt of honoraria for participation in Advisory Board from AstraZeneca, Boehringer Ingelheim, Genentech, Gritstone Oncology, Illumina, receipt of honoraria for consultancy from BioNTech, Novartis, RefleXion, Roche, has ownership interest with CiberMed, Foresight Diagnostics, receipt of royalties for licensing fees from Foresight Diagnostics, Roche Diagnostics, receipt of institutional financial interest as a coordinating PI from AstraZeneca, Varian, receipt of funding from Genentech, non-financial interest for receipt of reagents from Illumina, non-remunerated activities as a member of Board of Directors of Foresight Diagnostics, AI reports receipt of honoraria for participation in Advisory Board from Bayer, Chugai Pharmaceutical Co, GlaxoSmithKline, Philips, Roche, institutional non-financial interest as a coordinating PI from AstraZeneca, Bayer, Ipsen, Merck, Merck Sharp & Dohme (MSD) and Roche, JL reports receipt of honoraria to institution as invited speaker from Roche, JDM reports receipt of honoraria for participation in Advisory Board from Illumina, BMS, receipt of honoraria for consultancy from PierianDx, receipt of royalties for licensing fees administered by Stanford University from the United States Patent Office, non-remunerated activities as a member of Board of Directors of the Association for Molecular Pathology, non-remunerated leadership role as a Chair of the Informatics Subdivision of the Association for Molecular Pathology, non-remunerated leadership role as a Vice Chair of the CLSI MM23—Molecular Diagnostic Methods for Solid Tumors Committee of the Clinical and Laboratory Standards Institute (CLSI), non-remunerated activities in the US NIH/NCI as a PI for the NIH 1-UG1-CA233333-01, UNITS: The UNC/UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center, CM reports receipt of honoraria for participation in Advisory Board from Biocartis, Merck Serono, receipt of honoraria as invited speaker from Amgen, Guardant Health, Merck Serono, and Pierre Fabre, Roche, receipt of royalties for licensing fees administered by Institut Investigació Hospital del Mar, NN reports receipt of honoraria for participation in Advisory Board from AstraZeneca, Bayer, Biocartis, Incyte, Novartis, Qiagen, Roche, receipt of honoraria as invited speaker from BMS, Eli Lilly, Illumina, Merck, MSD, Sanofi, Thermo Fisher, receipt of institutional research grants from AstraZeneca, Biocartis, Blueprint, Illumina, Incyte, Merck, Qiagen, Roche, Thermo Fisher, leadership non-remunerated role as a President of the International Quality Network for Pathology (IQN Path) and President of the Italian Cancer Society (SIC), KP reports receipt of honoraria for participation in Advisory Board from MSD, Menarini, Hello Healthcare, Sanofi, receipt of honoraria as invited speaker from Abcam, Ipsen Pharma, Medac, Agena, institutional financial interest from Angle plc, European Liquid Biopsy Society, Böhringer Ingelheim and for participation in IMI JT ID Cancer from EU/IMI Cancer-ID consortium, SP reports receipt of honoraria for participation in Advisory Board from Amgen, AstraZeneca, Bayer, BeiGene, Blueprint, BMS, Boehringer Ingelheim, Daiichi Sankyo, Guardant Health, Janssen, Eli Lilly, Merck KGaA, Novartis, Roche, Takeda, institutional financial interest for research as a coordinating PI from Ariad, Boehringer Ingelheim, Celgene, Daiichi Sankyo, Takeda, Turning Point Therapeutics, as a local PI from AstraZeneca, GlaxoSmithKline, Roche, Trizell, as a sub-investigator from Amgen, MSD, non-remunerated advisory role in ALK Positive UK, International Association for the Study of Lung Cancer, Lung Cancer Europe, Ruth Strauss Foundation, non-remunerated leadership role in the British Thoracic Oncology Group as a Chair of Steering Committee, European Thoracic Oncology Platform as a Foundation Council Member, non-remunerated member of Thoracic malignancy Faculty in the European Society for Medical Oncology, non-remunerated member of Board of Directors in the Mesothelioma Applied Research Foundation, JSRF reports consultancy fees from Goldman Sachs, Repare Therapeutics, Paige.AI and Eli-Lilly, membership of the Board of Directors Group Oncoclinicas, stock ownership of Repare Therapeutics, and honoraria for ad hoc participation in the Scientific Advisory Board of Repare Therapeutics, Paige.AI, Roche Tissue Diagnostics, Novartis, Roche/Genentech, Invicro and Personalis, JT reports consultancy fee from Haystack Oncology, receipt of honoraria for participation in Advisory Board from AstraZeneca, BMS, MSD, Inivata, Pierre Fabre, receipt of honoraria as invited speaker from Merck Serono, Amgen and Servier, JS reports ownership interest as a co-founder of Mosaic Biomedicals SL, member of Board of Directors of Northern Biologics Inc., receipt of institutional research grants from Roche Glycart AG, Mosaic Biomedicals SL, Hoffmann-La Roche Ltd, Northern Biologics Inc., Ridgeline Therapeutics, non-remunerated activities as a member of Board of Directors of Asociación Española Contra el Cáncer and a member of Board of Directors, Secretary General of the European Association for Cancer Research (AACR), TY reports receipt of honoraria as invited speaker from Bayer, Chugai, Eli Lilly, Merck Biopharma, Ono, Taiho, receipt of institutional research grants from Amgen, MSD, Ono, Taiho, receipt of institutional financial interest as a local PI from Chugai, Daiichi Sankyo, MSD, Ono, Parexel International, Sanofi and Sumitomo Dainippon, NT reports receipt of honoraria for participation in Advisory Board from Arvinas, AstraZeneca, BMS, GlaxoSmithKline, Lilly, MSD, Novartis, Pfizer, Repare Therapeutics, Roche/Genentech, Zentalis Pharmaceuticals, institutional funding for research from AstraZeneca, MSD, Pfizer, Roche/Genentech, institutional non-financial interest for provision of material for research from BioRad and for provision of assays from Guardant Health. JS is co-founder of Mosaic Biomedicals and has ownership interests from Mosaic Biomedicals and Northern Biologics and reports receipt of grant/research support from Mosaic Biomedicals, Northern Biologics, Roche/Glycart and Hoffmann la Roche. All other authors have declared no conflicts of interest., This project was funded by the European Society for Medical Oncology (no grant number).

المصدر: ISSN: 0923-7534.

مصطلحات موضوعية: circulating tumour DNA (ctDNA), liquid biopsy, precision medicine, [SDV.CAN]Life Sciences [q-bio]/Cancer

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35809752; hal-03775791; https://hal.science/hal-03775791Test; https://hal.science/hal-03775791/documentTest; https://hal.science/hal-03775791/file/1-s2.0-S0923753422017215-main.pdfTest; PUBMED: 35809752

الإتاحة: https://doi.org/10.1016/j.annonc.2022.05.520Test
https://hal.science/hal-03775791Test
https://hal.science/hal-03775791/documentTest
https://hal.science/hal-03775791/file/1-s2.0-S0923753422017215-main.pdfTest

المؤلفون: De Mattos-Arruda, Leticia, Cortes, Javier, Blanco-Heredia, Juan, Tiezzi, Daniel G, Villacampa, Guillermo, Gonçalves-Ribeiro, Samuel, Paré, Laia, Souza, Carla Anjos, Ortega, Vanesa, Sammut, Stephen-John, Cusco, Pol, Fasani, Roberta, Chin, Suet-Feung, Perez-Garcia, Jose, Dienstmann, Rodrigo, Nuciforo, Paolo, Villagrasa, Patricia, Rubio, Isabel T, Prat, Aleix, Caldas, Carlos

مصطلحات موضوعية: 32 Biomedical and Clinical Sciences, 3211 Oncology and Carcinogenesis, 3204 Immunology, Women's Health, Cancer Genomics, Human Genome, Breast Cancer, Genetics, FOS Biological sciences, Cancer, 2.1 Biological and endogenous factors, 2 Aetiology, 3 Good Health and Well Being

الإتاحة: https://doi.org/10.17863/cam.72858Test
https://www.repository.cam.ac.uk/handle/1810/325402Test

المؤلفون: Quintana, Ángela, Peg, Vicente, Prat, Aleix, Moliné, Teresa, Villacampa, Guillermo, Paré, Laia, Galván, Patricia, Dientsmann, Rodrigo, Schmid, Peter, Curigliano, Giuseppe, Muñoz-Couselo, Eva, Perez-García, José, Marti, Merce, Blanco-Heredia, Juan, Anjos, Carla Dos, Vazquez, Miguel, De Mattos-Arruda, Leticia, Cortés, Javier

المساهمون: Á. Quintana, V. Peg, A. Prat, T. Moliné, G. Villacampa, L. Paré, P. Galván, R. Dientsmann, P. Schmid, G. Curigliano, E. Muñoz-Couselo, J. Perez-García, M. Marti, J. Blanco-Heredia, C.D. Anjo, M. Vazquez, L. De Mattos-Arruda, J. Cortés

مصطلحات موضوعية: Immune checkpoint inhibitor, Lymph node, Neoantigen, Triple-negative breast cancer, Tumor infiltrating lymphocytes, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33743482; info:eu-repo/semantics/altIdentifier/wos/WOS:000645079600017; volume:148; firstpage:134; lastpage:145; numberofpages:12; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/2434/826290Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85102636394

الإتاحة: https://doi.org/10.1016/j.ejca.2021.01.037Test
http://hdl.handle.net/2434/826290Test

المؤلفون: Cristofanilli, Massimo, Pierga, Jean-Yves, Reuben, James, Rademaker, Alfred, Davis, Andrew A., Peeters, Dieter J., Fehm, Tanja, Nolé, Franco, Gisbert-Criado, Rafael, Mavroudis, Dimitrios, Grisanti, Salvatore, Giuliano, Mario, Garcia-Saenz, Jose A., Stebbing, Justin, Caldas, Carlos, Gazzaniga, Paola, Manso, Luis, Zamarchi, Rita, de Lascoiti, Angela Fernandez, De Mattos-Arruda, Leticia, Ignatiadis, Michail, Cabel, Luc, van Laere, Steven J., Meier-Stiegen, Franziska, Sandri, Maria-Teresa, Vidal-Martinez, Jose, Politaki, Eleni, Consoli, Francesca, Generali, Daniele, Cappelletti, Maria Rosa, Diaz-Rubio, Eduardo, Krell, Jonathan, Dawson, Sarah-Jane, Raimondi, Cristina, Rutten, Annemie, Janni, Wolfgang, Munzone, Elisabetta, Carañana, Vicente, Agelaki, Sofia, Almici, Camillo, Dirix, Luc, Solomayer, Erich-Franz, Zorzino, Laura, Darrigues, Lauren, Reis-Filho, Jorge S., Gerratana, Lorenzo, Michiels, Stefan, Bidard, François-Clément, Pantel, Klaus

المساهمون: Cristofanilli, Massimo, Pierga, Jean-Yve, Reuben, Jame, Rademaker, Alfred, Davis, Andrew A., Peeters, Dieter J., Fehm, Tanja, Nolé, Franco, Gisbert-Criado, Rafael, Mavroudis, Dimitrio, Grisanti, Salvatore, Giuliano, Mario, Garcia-Saenz, Jose A., Stebbing, Justin, Caldas, Carlo, Gazzaniga, Paola, Manso, Lui, Zamarchi, Rita, de Lascoiti, Angela Fernandez, De Mattos-Arruda, Leticia, Ignatiadis, Michail, Cabel, Luc, van Laere, Steven J., Meier-Stiegen, Franziska, Sandri, Maria-Teresa, Vidal-Martinez, Jose, Politaki, Eleni, Consoli, Francesca, Generali, Daniele, Cappelletti, Maria Rosa, Diaz-Rubio, Eduardo, Krell, Jonathan, Dawson, Sarah-Jane, Raimondi, Cristina, Rutten, Annemie, Janni, Wolfgang, Munzone, Elisabetta, Carañana, Vicente, Agelaki, Sofia, Almici, Camillo, Dirix, Luc, Solomayer, Erich-Franz, Zorzino, Laura, Darrigues, Lauren, Reis-Filho, Jorge S., Gerratana, Lorenzo, Michiels, Stefan, Bidard, François-Clément, Pantel, Klaus

مصطلحات موضوعية: circulating tumor cell, CTC, metastatic breast cancer, MB, biomarker, survival

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30771872; info:eu-repo/semantics/altIdentifier/wos/WOS:000460712600005; volume:134; firstpage:39; lastpage:45; numberofpages:7; journal:CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY; http://hdl.handle.net/11368/2935442Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85059001216; https://www.sciencedirect.com/science/article/pii/S1040842818305109?via%3DihubTest

الإتاحة: https://doi.org/10.1016/j.critrevonc.2018.12.004Test
http://hdl.handle.net/11368/2935442Test
https://www.sciencedirect.com/science/article/pii/S1040842818305109?via%3DihubTest

المؤلفون: Invernizzi, Marco, Lopez, Gianluca, Michelotti, Anna, Venetis, Konstantinos, Sajjadi, Elham, De Mattos-Arruda, Leticia, Ghidini, Michele, Runza, Letterio, de Sire, Alessandro, Boldorini, Renzo, Fusco, Nicola

المساهمون: M. Invernizzi, G. Lopez, A. Michelotti, K. Veneti, E. Sajjadi, L. De Mattos-Arruda, M. Ghidini, L. Runza, A. de Sire, R. Boldorini, N. Fusco

مصطلحات موضوعية: breast cancer, breast cancer related lymphedema, genetic, pathobiology, quality of life, survivorship, Settore MED/08 - Anatomia Patologica, Settore MED/34 - Medicina Fisica e Riabilitativa, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32300557; info:eu-repo/semantics/altIdentifier/wos/WOS:000596896400001; volume:10; journal:FRONTIERS IN ONCOLOGY; http://hdl.handle.net/2434/728027Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85083520877

الإتاحة: https://doi.org/10.3389/fonc.2020.00422Test
http://hdl.handle.net/2434/728027Test